Table of Content
1. Executive Summary
2. Global Onychomycosis Treatment Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Onychomycosis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Onychomycosis Treatment Market by Disease Type
3.3.1: Distal Subungual Onychomycosis
3.3.2: Proximal Subungual Onychomycosis
3.3.3: White Superficial Onychomycosis
3.3.4: Candidal Onychomycosis
3.3.5: Others
3.4: Global Onychomycosis Treatment Market by Treatment Type
3.4.1: Laser Therapy
3.4.2: Photodynamic Therapy
3.4.3: Drug Treatment
3.5: Global Onychomycosis Treatment Market by Drug Class
3.5.1: Allylamine
3.5.2: Azole
3.5.3: Griseofulvin
3.5.4: Others
3.6: Global Onychomycosis Treatment Market by Distribution Channel
3.6.1: Hospitals and Clinics
3.6.2: Online Stores
3.6.3: Retail Pharmacies
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Onychomycosis Treatment Market by Region
4.2: North American Onychomycosis Treatment Market
4.2.1: North American Onychomycosis Treatment Market by Disease Type: Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others
4.2.2: North American Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others
4.3: European Onychomycosis Treatment Market
4.3.1: European Onychomycosis Treatment Market by Disease Type: Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others
4.3.2: European Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others
4.4: APAC Onychomycosis Treatment Market
4.4.1: APAC Onychomycosis Treatment Market by Disease Type: Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others
4.4.2: APAC Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others
4.5: ROW Onychomycosis Treatment Market
4.5.1: ROW Onychomycosis Treatment Market by Disease Type: Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others
4.5.2: ROW Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Onychomycosis Treatment Market by Disease Type
6.1.2: Growth Opportunities for the Global Onychomycosis Treatment Market by Treatment Type
6.1.3: Growth Opportunities for the Global Onychomycosis Treatment Market by Drug Class
6.1.4: Growth Opportunities for the Global Onychomycosis Treatment Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Onychomycosis Treatment Market by Region
6.2: Emerging Trends in the Global Onychomycosis Treatment Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Onychomycosis Treatment Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Onychomycosis Treatment Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bausch Health
7.2: Cipla
7.3: Dr. Reddy’s Laboratories
7.4: Galderma
7.5: GlaxoSmithKline
7.6: Kaken Pharmaceutical
7.7: Lumenis
7.8: Moberg Pharma
7.9: Novartis
7.10: Pfizer